Historic Events

Beximco Pharma Enters EU Pharmaceutical Market: Ophthalmic Products are Shipped to Germany and Austria

Beximco Pharmaceuticals Limited has commenced export of medicines to Europe. This was the very first time a local pharmaceutical company started exporting ophthalmic products to Europe. A signing ceremony was held at the factory premise of Beximco Pharma to mark the first consignment to Europe in presence of high officials of the company and representatives from DHL and Emirates Airlines.

Initially two ophthalmic products, Latanoprost and a combination of Latanoprost and Timolol, are being exported to Germany and Austria with other EU member countries to follow. Latanoprost and Timolol are used to reduce the pressure inside the eye for people with open-angle glaucoma or intraocular hypertension (increased pressure in the eye). The Company expects to launch a number of other products in Europe later this year.
Beximco Pharma is currently the largest exporter of pharmaceuticals in Bangladesh, with highest number of international accreditations in the pharma sector.

On this occasion, the Managing Director of Beximco Pharma, Nazmul Hassan MP says:
“Beximco has been building its presence in the emerging and developed markets, particularly having a focus on US and EU. We are aware of greater opportunity in generics as drugs worth billions of dollars are going off patent every year and rising healthcare costs have become a major concern worldwide. The governments around the world are now promoting access to generics and companies like Beximco Pharma can gain from this owing to its strong generic drug skills and cost advantages. We will continue to expand our portfolio in Europe, the 2nd largest pharmaceutical market in the world with sales in excess of US$ 265 billion, and provide affordable treatment options in those markets.”

News Feed

Beximco Pharmaceuticals Limited (“BPL” or “the Company”; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces that it has commenced export of Company products to Europe.

Initially shipments of two ophthalmic products, Latanoprost and a combination of Latanoprost and Timolol, will be exported to Germany and Austria with other EU countries to follow. Latanoprost and Timolol are used to reduce the pressure inside the eye for people with open-angle glaucoma or intraocular hypertension (increased pressure in the eye). The Company expects to launch additional new products in the EU later this year.

Read more...

Beximco Pharmaceuticals Limited has commenced export of medicines to Europe.
This was the very first time a local pharma company exported ophthalmic products to Europe. A signing ceremony was held on the factory premise of Beximco Pharma to mark the first consignment to Europe in presence of high officials of the company and representatives from DHL and Emirates.

Read more...

Beximco Pharmaceuticals Limited (BPL), a Bangladesh-based manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, has started to export its products to Europe with shipments of two ophthalmic products, Latanoprost and a combination of Latanoprost and Timolol.

Read more...

Bangladesh-based generic drugs and active pharmaceutical ingredients (API) company Beximco Pharmaceuticals...

Read more...